Literature DB >> 25573803

Dual function of IL-33 on proliferation of NIH-3T3 cells.

Shin-Ichi Tominaga1, Kenji Tago2, Hidetoshi Tsuda3, Mayumi Komine3.   

Abstract

The interleukin-33 (IL-33)-ST2L signaling pathway has been shown to play important roles in the field of immunology, especially as a trigger for allergic reactions such as bronchial asthma. However, coming back to the original finding that the ST2 gene is induced during initiation of the cell cycle of fibroblastic cell lines, the possible functions of the ST2 gene products and their specific ligand, IL-33, in the field of cell growth regulation are still interesting problems to be solved. In this study, we used NIH-3T3 mouse cell line and added IL-33 before and after cell proliferation assay, which revealed the dual function of IL-33. When IL-33 was added to the confluent cells before the start of cell proliferation, it suppressed the cell growth concentration-dependently. On the other hand, if IL-33 was added after the start of cell proliferation, it enhanced the cell growth. The negative effect of IL-33 on cell proliferation is a novel finding and would provide an important clue to the roles of IL-33 and ST2/ST2L in growth regulation.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell growth; Fibroblast; IL-33; NIH-3T3 cells; ST2 gene

Mesh:

Substances:

Year:  2015        PMID: 25573803     DOI: 10.1016/j.cyto.2014.12.004

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  6 in total

Review 1.  IL-33 in Tumor Immunity: Nothing to Sneeze At.

Authors:  Donye Dominguez; Yi Zhang; Bin Zhang
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

2.  Structure-Activity relationship of 1-(Furan-2ylmethyl)Pyrrolidine-Based Stimulation-2 (ST2) inhibitors for treating graft versus host disease.

Authors:  Xinrui Yuan; Hua Jiang; Denggang Fu; Aaron Robida; Krishani Rajanayake; Hebao Yuan; Bo Wen; Duxin Sun; Brennan T Watch; Krishnapriya Chinnaswamy; Jeanne A Stuckey; Sophie Paczesny; Jason C Rech; Chao-Yie Yang
Journal:  Bioorg Med Chem       Date:  2022-07-22       Impact factor: 3.461

3.  From proteomics to discovery of first-in-class ST2 inhibitors active in vivo.

Authors:  Abdulraouf M Ramadan; Etienne Daguindau; Jason C Rech; Krishnapriya Chinnaswamy; Jilu Zhang; Greg L Hura; Brad Griesenauer; Zachary Bolten; Aaron Robida; Martha Larsen; Jeanne A Stuckey; Chao-Yie Yang; Sophie Paczesny
Journal:  JCI Insight       Date:  2018-07-26

4.  Soluble form of the ST2 gene product exhibits growth promoting activity in NIH-3T3 cells.

Authors:  Shin-Ichi Tominaga; Satoshi Ohta; Kenji Tago
Journal:  Biochem Biophys Rep       Date:  2015-11-21

5.  Deficiency in IL-33/ST2 Axis Reshapes Mitochondrial Metabolism in Lipopolysaccharide-Stimulated Macrophages.

Authors:  Huadan Xu; Liankun Sun; Yichun He; Xiaofeng Yuan; Junqi Niu; Jing Su; Dong Li
Journal:  Front Immunol       Date:  2019-02-01       Impact factor: 7.561

6.  Proinflammatory Interleukin-33 Induces Dichotomic Effects on Cell Proliferation in Normal Gastric Epithelium and Gastric Cancer.

Authors:  Laura Francesca Pisani; Gian Eugenio Tontini; Carmine Gentile; Beatrice Marinoni; Isabella Teani; Nicoletta Nandi; Pasquale Creo; Emanuele Asti; Luigi Bonavina; Maurizio Vecchi; Luca Pastorelli
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.